|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.820 USD | -4.55% |
|
+2.77% | -51.46% |
| 07-01 | Lexeo Therapeutics, Inc. - Special Call | |
| 06-18 | Lexeo Therapeutics Publishes Phase I/Ii Data for Lx2006 in Friedreich Ataxia in Jama Cardiology | CI |
| Market Cap | 378M 331M 305M 282M 535M 36.1B 544M 3.65B 1.43B 17.78B 1.42B 1.39B 61.13B | P/E 2026 * |
-4.11x | P/E 2027 * | -3.61x |
|---|---|---|---|---|---|
| Enterprise Value | 235M 206M 190M 175M 333M 22.46B 339M 2.27B 891M 11.06B 884M 865M 38.03B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 17.8x |
| Free-Float |
99.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexeo Therapeutics, Inc.
| 1 day | -4.55% | ||
| 1 week | +2.77% | ||
| Current month | +3.54% | ||
| 1 month | +10.30% | ||
| 3 months | -19.40% | ||
| 6 months | -40.64% | ||
| Current year | -51.46% |
| 1 week | 4.56 |  | 5.38 |
| 1 month | 4.33 | | 5.38 |
| Current year | 4.03 | | 10.75 |
| 1 year | 3.6 | | 10.99 |
| 3 years | 1.45 | | 22.33 |
| 5 years | 1.45 | | 22.33 |
| 10 years | 1.45 | | 22.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Townsend
CEO | Chief Executive Officer | 46 | 01/01/2020 |
Louis Tamayo
DFI | Director of Finance/CFO | 50 | 15/08/2025 |
| Chief Operating Officer | 47 | 02/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 78 | 01/11/2021 | |
Reinaldo Diaz
BRD | Director/Board Member | 72 | 01/02/2022 |
| Chairman | 72 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-01 | Sell | Chief Operating Officer | -4,666 | 0.0059% | ||
| 07-01 | Sell | Chief Financial Officer | -4,641 | 0.0059% | ||
| 07-01 | Sell | Chief Technology Officer | -22,306 | 0.0284% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.55% | +2.77% | +7.83% | - | 378M | |
| +1.84% | -0.66% | +59.82% | +94.48% | 54.88B | |
| +0.60% | -5.49% | +57.65% | +130.96% | 54.63B | |
| -2.24% | +3.59% | +17.75% | +469.23% | 25.06B | |
| -1.60% | -6.21% | -18.96% | -16.06% | 23.14B | |
| -1.69% | -1.27% | +39.51% | -8.30% | 19.87B | |
| +0.68% | +2.71% | +36.81% | -27.44% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +364.56% | 16.5B | |
| -2.42% | -3.72% | +47.02% | +635.77% | 15.75B | |
| -1.05% | +1.16% | +25.95% | +191.69% | 14.2B | |
| Average | -1.73% | +0.03% | +46.85% | +203.87% | 24.19B | |
| Weighted average by Cap. | -0.62% | -1.44% | +50.43% | +173.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.11M 5.35M 4.93M 4.55M 8.64M 583M 8.79M 58.91M 23.13M 287M 22.95M 22.45M 987M |
| Net income | -97.88M -85.61M -78.97M -72.93M -138M -9.34B -141M -944M -371M -4.6B -368M -360M -15.81B | -123M -108M -99.34M -91.75M -174M -11.74B -177M -1.19B -466M -5.79B -462M -452M -19.89B |
| Net Debt | -143M -125M -115M -107M -202M -13.64B -206M -1.38B -541M -6.72B -537M -525M -23.1B | -270M -236M -218M -201M -381M -25.72B -388M -2.6B -1.02B -12.67B -1.01B -991M -43.56B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | $4.820 | -4.55% | 744,607 |
| 09/07/26 | $5.050 | -4.36% | 971,123 |
| 08/07/26 | $5.280 | +10.23% | 1,169,895 |
| 07/07/26 | $4.790 | +4.13% | 1,267,757 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXEO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
